Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Albert Park

Clinical trials sponsored by Albert Park, explained in plain language.

Can an antiviral drug protect hearing in infants with congenital CMV?

Disease control Stopped early

This trial tests whether the antiviral drug valganciclovir can improve hearing and language outcomes in infants who have hearing loss due to congenital cytomegalovirus (CMV) infection. Infants aged 1 to 12 months with confirmed sensorineural hearing loss will receive either valga…

Phase 2 • Sponsor: Albert Park • Aim: Disease control

Last updated Aug 29, 2026 00:00 UTC